Literature DB >> 27585036

The Fibular Nerve Injury Method: A Reliable Assay to Identify and Test Factors That Repair Neuromuscular Junctions.

William Dalkin1, Thomas Taetzsch2, Gregorio Valdez3.   

Abstract

The neuromuscular junction (NMJ) undergoes deleterious structural and functional changes as a result of aging, injury and disease. Thus, it is imperative to understand the cellular and molecular changes involved in maintaining and repairing NMJs. For this purpose, we have developed a method to reliably and consistently examine regenerating NMJs in mice. This nerve injury method involves crushing the common fibular nerve as it passes over the lateral head of the gastrocnemius muscle tendon near the knee. Using 70 day old female mice, we demonstrate that motor axons begin to reinnervate previous postsynaptic targets within 7 days post-crush. They completely reoccupy their previous synaptic areas by 12 days. To determine the reliability of this injury method, we compared reinnervation rates between individual 70 day old female mice. We found that the number of reinnervated postsynaptic sites was similar between mice at 7, 9, and 12 days post-crush. To determine if this injury assay can also be used to compare molecular changes in muscles, we examined levels of the gamma-subunit of the muscle nicotinic receptor (gamma-AChR) and the muscle-specific kinase (MuSK). The gamma-AChR subunit and MuSK to are highly upregulated following denervation and return to normal levels following reinnervation of NMJs. We found a close relationship between transcript levels for these genes and innervation status of muscles. We believe that this method will accelerate our understanding of the cellular and molecular changes involved in repairing the NMJ and other synapses.

Entities:  

Mesh:

Year:  2016        PMID: 27585036      PMCID: PMC5091792          DOI: 10.3791/54186

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  21 in total

Review 1.  Development of the vertebrate neuromuscular junction.

Authors:  J R Sanes; J W Lichtman
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  Molecular mechanisms of cellular interactions in peripheral nerve regeneration.

Authors:  P Küry; G Stoll; H W Müller
Journal:  Curr Opin Neurol       Date:  2001-10       Impact factor: 5.710

4.  Pre-existing pathways promote precise projection patterns.

Authors:  Quyen T Nguyen; Joshua R Sanes; Jeff W Lichtman
Journal:  Nat Neurosci       Date:  2002-09       Impact factor: 24.884

5.  Motor axon regeneration and muscle reinnervation in young adult and aged animals.

Authors:  Hyuno Kang; Jeff W Lichtman
Journal:  J Neurosci       Date:  2013-12-11       Impact factor: 6.167

Review 6.  The sciatic nerve injury model in pre-clinical research.

Authors:  Stefano Geuna
Journal:  J Neurosci Methods       Date:  2015-01-25       Impact factor: 2.390

7.  Sciatic nerve injury: a simple and subtle model for investigating many aspects of nervous system damage and recovery.

Authors:  Luis E Savastano; Sergio R Laurito; Marcos R Fitt; Jorge A Rasmussen; Virginia Gonzalez Polo; Sean I Patterson
Journal:  J Neurosci Methods       Date:  2014-01-30       Impact factor: 2.390

8.  Myostatin deficiency is associated with an increase in number of total axons and motor axons innervating mouse tibialis anterior muscle.

Authors:  Stephanie Gay; Elodie Jublanc; Anne Bonnieu; Francis Bacou
Journal:  Muscle Nerve       Date:  2012-05       Impact factor: 3.217

Review 9.  Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury.

Authors:  Andrew D Gaudet; Phillip G Popovich; Matt S Ramer
Journal:  J Neuroinflammation       Date:  2011-08-30       Impact factor: 8.322

10.  Shared resistance to aging and ALS in neuromuscular junctions of specific muscles.

Authors:  Gregorio Valdez; Juan C Tapia; Jeff W Lichtman; Michael A Fox; Joshua R Sanes
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

View more
  7 in total

Review 1.  Effects of disease-afflicted and aging neurons on the musculoskeletal system.

Authors:  Gregorio Valdez
Journal:  Bone       Date:  2019-01-26       Impact factor: 4.398

2.  Roles of the synaptic molecules Hevin and SPARC in mouse neuromuscular junction development and repair.

Authors:  Vanessa L Brayman; Thomas Taetzsch; MacKenzie Miko; Shreyaska Dahal; W Christopher Risher; Gregorio Valdez
Journal:  Neurosci Lett       Date:  2021-01-22       Impact factor: 3.046

3.  Specific labeling of synaptic schwann cells reveals unique cellular and molecular features.

Authors:  Ryan Castro; Thomas Taetzsch; Sydney K Vaughan; Kerilyn Godbe; John Chappell; Robert E Settlage; Gregorio Valdez
Journal:  Elife       Date:  2020-06-25       Impact factor: 8.140

4.  Expression and Roles of Lynx1, a Modulator of Cholinergic Transmission, in Skeletal Muscles and Neuromuscular Junctions in Mice.

Authors:  Sydney V Doss; Sébastien Barbat-Artigas; Mikayla Lopes; Bhola Shankar Pradhan; Tomasz J Prószyński; Richard Robitaille; Gregorio Valdez
Journal:  Front Cell Dev Biol       Date:  2022-03-16

5.  Argonaute 2 is lost from neuromuscular junctions affected with amyotrophic lateral sclerosis in SOD1G93A mice.

Authors:  Dillon Shapiro; Ryan Massopust; Thomas Taetzsch; Gregorio Valdez
Journal:  Sci Rep       Date:  2022-03-17       Impact factor: 4.379

Review 6.  Age-Related Alterations at Neuromuscular Junction: Role of Oxidative Stress and Epigenetic Modifications.

Authors:  Gabriella Dobrowolny; Alessandra Barbiera; Gigliola Sica; Bianca Maria Scicchitano
Journal:  Cells       Date:  2021-05-24       Impact factor: 6.600

7.  Semaphorin3A Signaling Is Dispensable for Motor Axon Reinnervation of the Adult Neuromuscular Junction.

Authors:  Jennifer L Shadrach; Brian A Pierchala
Journal:  eNeuro       Date:  2018-05-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.